BIOSTAR PHARM-B Receives CSRC Filing Notice for Full Circulation of H Shares

Stock News02-06 22:52

BIOSTAR PHARM-B (02563) has announced that the company received a filing notice from the China Securities Regulatory Commission (CSRC) dated February 5, 2026. According to the notice, the company has completed the filing with the CSRC for the implementation of a full circulation of its H shares. The filing notice will be valid for 12 months from its date of issue. The company will apply to the Stock Exchange of Hong Kong for the conversion and listing of the shares. As of the date of this announcement, the specific details of the implementation plan for the conversion and listing have not been finalized. The company will issue further announcements regarding the progress and details of the conversion and listing at the appropriate time, in accordance with the Listing Rules and applicable laws.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1189658924?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-06 22:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1189658924","market":"sh","top_or_hot":-1,"title":"BIOSTAR PHARM-B Receives CSRC Filing Notice for Full Circulation of H Shares","media":"Stock News","content":"<p>BIOSTAR PHARM-B (02563) has announced that the company received a filing notice from the China Securities Regulatory Commission (CSRC) dated February 5, 2026. According to the notice, the company has completed the filing with the CSRC for the implementation of a full circulation of its H shares. The filing notice will be valid for 12 months from its date of issue. The company will apply to the Stock Exchange of Hong Kong for the conversion and listing of the shares. As of the date of this announcement, the specific details of the implementation plan for the conversion and listing have not been finalized. The company will issue further announcements regarding the progress and details of the conversion and listing at the appropriate time, in accordance with the Listing Rules and applicable laws.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BIOSTAR PHARM-B Receives CSRC Filing Notice for Full Circulation of H Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBIOSTAR PHARM-B Receives CSRC Filing Notice for Full Circulation of H Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-02-06 22:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BIOSTAR PHARM-B (02563) has announced that the company received a filing notice from the China Securities Regulatory Commission (CSRC) dated February 5, 2026. According to the notice, the company has completed the filing with the CSRC for the implementation of a full circulation of its H shares. The filing notice will be valid for 12 months from its date of issue. The company will apply to the Stock Exchange of Hong Kong for the conversion and listing of the shares. As of the date of this announcement, the specific details of the implementation plan for the conversion and listing have not been finalized. The company will issue further announcements regarding the progress and details of the conversion and listing at the appropriate time, in accordance with the Listing Rules and applicable laws.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"","article_id":"1189658924","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1189658924","pubTimestamp":1770389534,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"BIOSTAR PHARM-B (02563) has announced that the company received a filing notice from the China Securities Regulatory Commission (CSRC) dated February 5, 2026. According to the notice, the company has...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159938":"医药","BK1161":"生物科技","BK1574":"生物医药B类股","09939":"开拓药业-B","02563":"华昊中天医药-B","BK1515":"抗疫概念"},"translate_title":"映泰医药-B收到证监会H股全流通备案通知书","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159938":1,"02563":1,"09939":1},"content_text":"BIOSTAR PHARM-B (02563) has announced that the company received a filing notice from the China Securities Regulatory Commission (CSRC) dated February 5, 2026. According to the notice, the company has completed the filing with the CSRC for the implementation of a full circulation of its H shares. The filing notice will be valid for 12 months from its date of issue. The company will apply to the Stock Exchange of Hong Kong for the conversion and listing of the shares. As of the date of this announcement, the specific details of the implementation plan for the conversion and listing have not been finalized. The company will issue further announcements regarding the progress and details of the conversion and listing at the appropriate time, in accordance with the Listing Rules and applicable laws.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1189658924","isCrawlerRequest":true}